United States · Investor

Venrock

Last cheque observed Oct 2026; 560 cheques on record.

Deploying nowNew fund $650M, Jan 2024VC firm

Pre-seedSeedSeries AHealthConnected HealthDigital-health

Deploying now
84%of best year21cheques in 12 months, 560 on record
Since the last cheque17days00hrs00min00sec
Median round$36MCheque size, as they say$1.0M – $100MRounds led3 of 560Sole investor59 roundsExits75 from the portfolioMostly inUnited States, 90%
Pitch Venrock

Venrock highlights

  1. 01

    21 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 51% of its rounds

  3. 03

    Sole investor in 59 rounds, median $10M

  4. 04

    75 exits from the portfolio

What they do

Filed 5 private fund offerings with the SEC, the most recent in 2024-01From their own website
Type
VC firm (from a list, unverified)
Cheque size
$1.0M – $100M as they say
Stages
Pre-seedSeedSeries ASeries BGrowthPre-IPO
Sectors
HealthConnected HealthDigital-health
Based in
Palo Alto, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first560 appearances

  1. 2026

    16 rounds

  2. Oct
    SukiSeries E · US · Google News search$90MWith 7 others
  3. Sept
    Encoded TherapeuticsSeries F · US$275MWith 4 others
  4. Aug
    Aligned MarketplaceSeries A · US · AlleyWatch$16MLed
  5. Aug
    Expedition TherapeuticsSeries B · US$115MWith 3 others
  6. Jun
    cAMPfield Therapeutics, Inc.Series A · US · Frazier Life Sciences$180MWith 7 others
  7. Jun
    SonoTheraSeries B · US · Ventureburn$125MWith 10 others
  8. Jun
    Element BiosciencesGrowth · US · Ventureburn$175MWith 4 others
  9. Jun
    Jade BiosciencesUS$150MWith 4 others
  10. Jun
    Arca WealthSeries A · US$49MWith 2 others
  11. May
    MomentSeries C · Ventureburn$78MWith 5 others
  12. May
    GenLogsVenture · USUndisclosedWith 4 others
  13. May
    PharvarisCH$132MWith 4 others
  14. Feb
    SkyryseSeries C · US · TechCrunch$300MWith 14 others
  15. Feb
    Coherus BiosciencesUS$50MWith 3 others
  16. Feb
    PortersPre-seed · CH$3.2MWith 5 others
  17. Feb
    GenLogsSeries B · US$60MWith 4 others
  18. 2025

    24 rounds

  19. Dec
    FINNYSeries A · US$17MWith 3 others
  20. Dec
    Jade BiosciencesUS$45MWith 4 others
  21. Dec
    AledadeDebt · US$500MWith 4 others
  22. Nov
    Archetype AISeries A · US · TechStartups$35MWith 10 others
  23. Nov
    Biohaven PharmaceuticalUS$200MWith 3 others
  24. Oct
    SylloUS · AlleyWatch$30MWith 2 others
  25. Oct
    Averto MedicalGrant · US$2.1MWith 3 others
  26. Oct
    Expedition TherapeuticsSeries A · US$165MWith 3 others
  27. Oct
    SkyryseSeries C · US$167MWith 4 others
  28. Sept
    Euclid PowerSeries A · US$20MWith 3 others
  29. Sept
    KalVista PharmaceuticalsDebt · US$125MWith 4 others
  30. Jul
    MomentSeries B · US · AlleyWatch$36MWith 8 others
  31. Jul
    CollateSeries A · US$10MWith 2 others
  32. Jun
    Zero NetworksGrowth · IL · TechStartups$55MWith 4 others
  33. May
    Adyton PBCVenture · US$11MWith 4 others
  34. May
    Mahzi TherapeuticsGrant · US$4.0MSole investor
  35. May
    AstronomerSeries D · US · Crunchbase News$93MWith 8 others
  36. Apr
    AltruistSeries F · US$152MWith 5 others
  37. Mar
    GetReal SecuritySeries A · US$18MWith 5 others
  38. Feb
    GH ResearchIE$150MWith 4 others
  39. Feb
    Auditoria.AISeries B · US$38MWith 2 others
  40. Feb
    ExceedsSeed · US$4.6MSole investor
  41. Jan
    OumiSeed · US$10MWith 3 others
  42. Jan
    Timberlyne TherapeuticsSeries A · US$180MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration17 named

ADAnders D. HoveA Member of the General PartneriFiling they signed
BPBob P. KocherManageriFiling they signed
BYBong Young KohA Manager of the General PartneriFiling they signed
BDBrian David AscherMember of the General Partner to IssueriFiling they signed
BEBryan Edward RobertsMember of the General Partner to IssueriFiling they signed
CDCamille Danielle SamuelsMember of the General Partner to IssueriFiling they signed
DBDavid B. PakmanMember of the General Partner to IssueriFiling they signed
EJEthan James BatraskiManaging Member of the General PartneriFiling they signed
EWEvan Wolfe NeuPartner and General Counsel of Vr Management, LLCiForm ADV
GEGanesh E. SrinivasanManaging Member of the General PartneriFiling they signed
LDLisa Denise HarrisChief Financial Officer of Vr Management, LLCiForm ADV
MFMichael Frederick TyrrellMember of the General Partner to IssueriFiling they signed
NFNicholas Frederick BeimMember of Venrock Management Vii, LLCiForm ADV
NFNick F. BeimMember of the General Partner to IssueriFiling they signed
NSNimish ShahA Manager of the General PartneriFiling they signed
RNRacquel Noh BrackenManaging Member of the General PartneriFiling they signed
RPRobert Paul KocherMember of the General Partner to IssueriFiling they signed

We also hold 41 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$4.5Bgross assets of its fundsOct 2026
3+funds on filenumbered funds in its name
Exemptreporting adviserventure or small private funds
Legal name
Venrock Management, LLC
SEC number
CRD 161269

Exits from the portfolio

Companies it backed that were later bought or listed75 in all

GazelleBought by Outerwall$18MNov 2015
ReceptosBought by Celgene$7.3BJul 2015
Martini MediaBought by Evolve Media, LLCUndisclosedJun 2015
AtrentaBought by SynopsysUndisclosedJun 2015
BoundlessBought by Valore BooksUndisclosedApr 2015
IkariaBought by Mallinckrodt$2.3BMar 2015
Ariosa Diagnostics, Inc.Bought by Roche$625MDec 2014
AppiaBought by Digital Turbine$100MNov 2014
BlogHerBought by SheKnows MediaUndisclosedNov 2014
Kineto WirelessBought by TaquaUndisclosedSept 2014
BizoBought by LinkedIn$175MJul 2014
Newport MediaBought by AtmelUndisclosedJul 2014
Chelsea Therapeutics InternationalBought by LundbeckUndisclosedMay 2014
KloutBought by Lithium Technologies$200MMar 2014
Nest LabsBought by Google$3.2BJan 2014
CrunchyrollBought by Otter MediaUndisclosedDec 2013
SinglyBought by AppceleratorUndisclosedAug 2013
ACADIA PharmaceuticalsListed$115MMay 2013
CoreTraceBought by LumensionUndisclosedNov 2012
LinkedIn SlideShareBought by LinkedIn$119MMay 2012

The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Venrock. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Venrock put money into.

On podcasts

6 episodes naming Venrock in the title, and 4 more that mention it.

Mentioned in

Quick answers about Venrock

What does Venrock invest in?

Venrock invests most often at Series B and Series A (51% of the rounds on record), in sectors such as Health, Connected Health and Digital-health.

How active is Venrock?

560 investments on record, 21 of them in the last 12 months, and it led 3. The most recent was in Oct 2026.

What has Venrock invested in recently?

Its most recent investments on record: Suki (Series E, Oct 2026), Encoded Therapeutics (Series F, Sept 2026) and Aligned Marketplace (Series A, Aug 2026).

How big are Venrock's cheques?

The median round it joins is $36M. It says it writes cheques of $1.0M to $100M.

Does Venrock lead rounds?

Sometimes: it led 3 of its 560 investments on record (1%).

Where does Venrock invest?

Most of the companies it backs are in the United States (90%) and Switzerland (5%).

Is Venrock investing now?

Yes: it is actively investing, with 21 investments in the last 12 months.

Who does Venrock invest alongside?

Most often U.S. Venture Partners (36 rounds together), ARCH Venture Partners (27 rounds together) and RA Capital Management (25 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it